These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9254793)
21. [Toxic hepatitis after exposure to dimethylformamide]. Lundberg I; Liljelund K; Löfmark R Lakartidningen; 1990 Nov; 87(46):3872-3. PubMed ID: 2233067 [No Abstract] [Full Text] [Related]
22. [Hepatitis imputable to dimethylformamide with reintroduction]. Drouet D'Aubigny F; Roquelaure Y; Bertrand L; Caillon M; Calès P Gastroenterol Clin Biol; 1998; 22(8-9):745-6. PubMed ID: 9823570 [No Abstract] [Full Text] [Related]
23. The fast track: federal agencies and the political demand for AIDS drugs. Foreman CH Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828 [No Abstract] [Full Text] [Related]
24. PHS proposes 'parallel track' for new AIDS drugs. Public Health Rep; 1990; 105(5):541-2. PubMed ID: 2120736 [No Abstract] [Full Text] [Related]
25. Row over controversial new AIDS drug. Buderi R Nature; 1989 Sep; 341(6240):267. PubMed ID: 2677738 [No Abstract] [Full Text] [Related]
27. [Acute hepatic disorders after exposure to dimethylformamide. Clinical and histological aspects]. Riachi G; Michel P; François A; Ducrotté P; Laffineur G; Lerebours E; Colin R Gastroenterol Clin Biol; 1993; 17(8-9):611-2. PubMed ID: 8253328 [No Abstract] [Full Text] [Related]
28. Researchers' offices raided over banned AIDS drug. Sidley P BMJ; 1997 Dec; 315(7121):1486. PubMed ID: 9420486 [No Abstract] [Full Text] [Related]
29. New B-M group 'AIDS' drug for 'investigational use'. Nurs RSA; 1990 Jan; 5(1):46. PubMed ID: 2108332 [No Abstract] [Full Text] [Related]
30. South Africa may keep door closed to generic AIDS drugs. Cherry M Nature; 2001 Apr; 410(6832):1013. PubMed ID: 11323627 [No Abstract] [Full Text] [Related]
31. Viramune Expanded Access Program begins. AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361629 [No Abstract] [Full Text] [Related]
32. When science and passion meet: the impact of AIDS on research. Pripstein J CMAJ; 1993 Feb; 148(4):638-42. PubMed ID: 8431829 [No Abstract] [Full Text] [Related]
33. Immune reconstitution hepatitis E: a neglected complication of antiretroviral therapy in Africa? Andersson MI; Preiser W; Maponga TG; Heys I; Taljaard JJ; van Rensburg C; Tedder RS; Ijaz S AIDS; 2013 Jan; 27(3):487-9. PubMed ID: 23291543 [No Abstract] [Full Text] [Related]
34. 124 drugs currently in development. AIDS Patient Care STDS; 1998 Feb; 12(2):149. PubMed ID: 11361916 [No Abstract] [Full Text] [Related]
35. South African firm gets US approval for AIDS drugs. AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15846847 [No Abstract] [Full Text] [Related]
36. Preventing adverse health effects from exposure to dimethylformamide (DMF). NIOSH Am Ind Hyg Assoc J; 1991 Mar; 52(3):A160, A162. PubMed ID: 2028916 [No Abstract] [Full Text] [Related]
37. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule. Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458 [TBL] [Abstract][Full Text] [Related]
38. Experts clash over likely impact of cheap AIDS drugs in Africa. Wadman M Nature; 2001 Apr; 410(6829):615-6. PubMed ID: 11287906 [No Abstract] [Full Text] [Related]
39. South Africa stalls again on access to HIV drugs. Baleta A Lancet; 2003 Mar; 361(9360):842. PubMed ID: 12642059 [No Abstract] [Full Text] [Related]
40. IOM panel exonerates researchers in FIAU deaths. Marwick C JAMA; 1995 Apr; 273(15):1165. PubMed ID: 7707610 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]